Am. J. Respir. Crit. Care Med., Vol 153, No. 1, Jan 1996, 90-96.
Inflammatory cell populations in bronchial biopsies from aspirin- sensitive asthmatic subjects
SM Nasser, R Pfister, PE Christie, AR Sousa, J Barker, M Schmitz-Schumann and TH Lee
Department of Allergy and Respiratory Medicine, UMDS, Guy's Hospital, London, United Kingdom.
The inflammatory cell infiltrate in bronchial biopsies of 12 aspirin-
sensitive asthmatic (ASA) subjects and eight non-aspirin-sensitive (non-
ASA) control subjects have been compared. Biopsies were taken from a right
middle or lower lobe segmental carina using fiberoptic bronchoscopy. The
biopsies were snap-frozen in OCT, and sections 5 microns thick were doubled
immunostained using a rabbit polyclonal antibody to the enzyme
5-lipoxygenase (5-LO) and with a monoclonal antibody to neutrophils (NP57),
macrophages (EMB11), and total (BMK13) and activated eosinophils (EG2),
mast cells (AA1), and T-lymphocytes (anti-CD3). There was no significant
difference in the total numbers of cells staining for 5-LO between the two
groups of subjects. As a percentage of total 5-LO cells, there were
significantly more mast cells (12.9 +/- 3.8% versus 3.4 +/- 3.1%; p =
0.039) and total eosinophils (34.7 +/- 9.4% versus 11.1 +/- 3.8%; p =
0.044) and significantly fewer macrophages (23.3 +/- 6.1% versus 39.8% +/-
5.3; p = 0.041) in the bronchial biopsies from ASA subjects as compared
with non-ASA patients. The numbers of neutrophils, T-lymphocytes, and
activated eosinophils were similar for the two groups. The increased
numbers of eosinophils and mast cells identified in the bronchial tissue
from aspirin-sensitive asthmatic subjects may be the source of the enhanced
cysteinyl leukotriene production observed in these subjects.
This article has been cited by other articles:

|
 |

|
 |
 
J.-W. Min, A.-S. Jang, S.-M. Park, S.-H. Lee, J.-H. Lee, S.-W. Park, and C.-S. Park
Comparison of Plasma Eotaxin Family Level in Aspirin-Induced and Aspirin-Tolerant Asthma Patients
Chest,
November 1, 2005;
128(5):
3127 - 3132.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.K.C. Lee, K. Haggart, F.M. Robb, and B.J. Lipworth
Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma
Eur. Respir. J.,
August 1, 2004;
24(2):
226 - 230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Sousa, A. Parikh, G. Scadding, C. J. Corrigan, and T. H. Lee
Leukotriene-Receptor Expression on Nasal Mucosal Inflammatory Cells in Aspirin-Sensitive Rhinosinusitis
N. Engl. J. Med.,
November 7, 2002;
347(19):
1493 - 1499.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. OGUMA, K. ASANO, T. SHIOMI, K. FUKUNAGA, Y. SUZUKI, M. NAKAMURA, H. MATSUBARA, H. K. SHELDON, K. J. HALEY, C. M. LILLY, et al.
Cyclooxygenase-2 Expression during Allergic Inflammation in Guinea-Pig Lungs
Am. J. Respir. Crit. Care Med.,
February 1, 2002;
165(3):
382 - 386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Casadevall, P-J Ventura, J Mullol, and C Picado
Intranasal challenge with aspirin in the diagnosis of aspirin intolerant asthma: evaluation of nasal response by acoustic rhinometry
Thorax,
November 1, 2000;
55(11):
921 - 924.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Sanak and A. Szczeklik
Genetics of aspirin induced asthma
Thorax,
October 1, 2000;
55(90002):
45S - 47.
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Simonds
New developments in the treatment of obstructive sleep apnoea
Thorax,
August 1, 2000;
55(90001):
S45 - 50.
[PDF]
|
 |
|

|
 |

|
 |
 
J. BOUSQUET, P. K. JEFFERY, W. W. BUSSE, M. JOHNSON, and A. M. VIGNOLA
Asthma . From Bronchoconstriction to Airways Inflammation and Remodeling
Am. J. Respir. Crit. Care Med.,
May 1, 2000;
161(5):
1720 - 1745.
[Full Text]
|
 |
|

|
 |

|
 |
 
J. C. KIPS, B. J. O'CONNOR, M. D. INMAN, K. SVENSSON, R. A. PAUWELS, and P. M. O'BYRNE
A Long-term Study of the Antiinflammatory Effect of Low-dose Budesonide Plus Formoterol versus High-dose Budesonide in Asthma
Am. J. Respir. Crit. Care Med.,
March 1, 2000;
161(3):
996 - 1001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. SZCZEKLIK and M. SANAK
Genetic Mechanisms in Aspirin-induced Asthma
Am. J. Respir. Crit. Care Med.,
February 1, 2000;
161(2):
S142 - 146.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. E. A. LAMS, A. R. SOUSA, P. J. REES, and T. H. LEE
Immunopathology of the Small-Airway Submucosa in Smokers with and without Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
November 1, 1998;
158(5):
1518 - 1523.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. SOUSA, B. E. A. LAMS, R. PFISTER, P. E. CHRISTIE, M. SCHMITZ, and T. H. LEE
Expression of Interleukin-5 and Granulocyte-Macrophage Colony-stimulating Factor in Aspirin-sensitive and Non-Aspirin-sensitive Asthmatic Airways
Am. J. Respir. Crit. Care Med.,
November 1, 1997;
156(5):
1384 - 1389.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1996 American Thoracic Society
|
|
|